Raymond James Financial’s Cellectar Biosciences CLRB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$946 Buy
+133
New +$946 ﹤0.01% 6490